REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Laboratorios Lebriut S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Laboratorios Lebriut S.A.S. Profile Updated: March 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Laboratorios Lebriut S.A.S. is an enterprise based in Colombia. Its main office is in Sabaneta. It operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on May 11, 2011. There was a net sales revenue increase of 75.67% reported in Laboratorios Lebriut S.A.S.’s latest financial highlights for 2025. A growth of 20.63% was recorded in its total assets. The net profit margin of Laboratorios Lebriut S.A.S. increased by 9.81% in 2025.

Headquarters
Cr 43A # 61 Sur 84
Sabaneta; Antioquia;

Contact Details: Purchase the Laboratorios Lebriut S.A.S. report to view the information.

Basic Information
Financial Auditors:
Purchase the Laboratorios Lebriut S.A.S. report to view the information.
Incorporation Date:
May 11, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Laboratorios Lebriut S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
75.67%▲
Total Operating Revenue
75.67%▲
EBITDA
514.15%▲
Net Profit/Loss for the Period
5020.87%▲
Total Assets
20.63%▲
Total Equity
19.81%▲
Net Profit Margin
9.81%▲
Return on Equity (ROE)
16.15%▲
Quick Ratio
-9.12%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo